Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case

American Journal of Medical Genetics, Part A

Volumn 152 A, Issue 12, 2010, Pages 3164-3172

  Petrin, Aline L ^a   Giacheti, Célia M ^b   Maximino, Luciana P ^c   Abramides, Dagma V M ^c   Zanchetta, Sthella ^c   Rossi, Natalia F ^b   Richieri Costa, Antônio ^c   Murray, Jeffrey C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CNTNAP2; Microdeletion; Stuttering

Indexed keywords

CONTACTIN; CONTACTIN ASSOCIATED PROTEIN LIKE 2; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; BRAIN ATROPHY; CASE REPORT; CHILD; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; EXON; FEMALE; FLUENCY DISORDER; GENE DELETION; GENE DISRUPTION; HEMIZYGOSITY; HUMAN; LANGUAGE DISABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SPEECH DISORDER; STUTTERING;

BRAZIL; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; LANGUAGE DISORDERS; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR FAMILY; STUTTERING;

EID: 78649665537     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33749     Document Type: Article

References (40)

1. Abrahams BS, Tentler D, Perederiy JV, Oldham MC, Coppola G, Geschwind DH. 2007. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc Natl Acad Sci USA 104: 17849-17854.
2. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF, Cantor RM, Geschwind DH. 2008. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 82: 150-159.
3. Ambrose NG, Yairi E, Cox N. 1993. Genetic aspects of early childhood stuttering. J Speech Hear Res 36: 701-706.
4. Andrews JG. 1964. The nature of stuttering. Med J Aust 2: 919-924.
5. Andrews G, Morris-Yates A, Howie P, Martin NG. 1991. Genetic factors in stuttering confirmed. Arch Gen Psychiatry 48: 1034-1035.
6. Baxter MG, Chiba AA. 1999. Cognitive functions of the basal forebrain. Curr Opin Neurobiol 9: 178-183.
7. Bellen HJ, Lu Y, Beckstead R, Bhat MA. 1998. Neurexin IV, caspr and paranodin-novel members of the neurexin family: Encounters of axons and glia. Trends Neurosci 21: 444-449.
8. Belloso JM, Bache I, Guitart M, Caballin MR, Halgren C, Kirchhoff M, Ropers HH, Tommerup N, Tumer Z. 2007. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet 15: 711-713.
9. Buchel C, Sommer M. 2004. What causes stuttering? PLoS Biol 2: E46.
10. Canhetti-Oliveira CM, Richieri-Costa A. 2006. A study of familial stuttering. Am J Med Genet Part A 140A: 2139-2141.
11. Carey GJ, Billard W, Binch H III, Cohen-Williams M, Crosby G, Grzelak M, Guzik H, Kozlowski JA, Lowe DB, Pond AJ, Tedesco RP, Watkins RW, Coffin VL. 2001. SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431: 189-200.
12. Conture EG, Kelly EM. 1991. Young stutterers' nonspeech behaviors during stuttering. J Speech Hear Res 34: 1041-1056.
13. Felsenfeld S. 2002. Finding susceptibility genes for developmental disorders of speech: The long and winding road. J Commun Disord 35: 329-345.
14. Felsenfeld S, Kirk KM, Zhu G, Statham DJ, Neale MC, Martin NG. 2000. A study of the genetic and environmental etiology of stuttering in a selected twin sample. Behav Genet 30: 359-366.
15. Fenech AG, Billington CK, Swan C, Richards S, Hunter T, Ebejer MJ, Felice AE, Ellul-Micallef R, Hall IP. 2004. Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle. Am J Respir Cell Mol Biol 30: 678-686.
16. Gautam D, Duttaroy A, Cui Y, Han SJ, Deng C, Seeger T, Alzheimer C, Wess J. 2006. M1-M3 muscarinic acetylcholine receptor-deficient mice: Novel phenotypes. J Mol Neurosci 30: 157-160.
17. Gosso FM, de Geus EJ, Polderman TJ, Boomsma DI, Posthuma D, Heutink P. 2007. Exploring the functional role of the CHRM2 gene in human cognition: Results from a dense genotyping and brain expression study. BMC Med Genet 8: 66.
18. Kang C, Riazuddin S, Mundorff J, Krasnewich D, Friedman P, Mullikin JC, Drayna D. 2010. Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering. N Engl J Med 362: 677-685.
19. Levelt WJ. 1999. Models of word production. Trends Cogn Sci 3: 223-232.
20. Lu C, Ning N, Peng D, Ding G, Li K, Yang Y, Lin C. 2009. The role of large-scale neural interactions for developmental stuttering. Neuroscience 161: 1008-1026.
21. Lu C, Peng D, Chen C, Ning N, Ding G, Li K, Yang Y, Lin C. 2010. Altered effective connectivity and anomalous anatomy in the basal ganglia-thalamocortical circuit of stuttering speakers. Cortex 46: 49-67. [Epub 2009 Mar 13].
22. Orsetti M, Casamenti F, Pepeu G. 1996. Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res 724: 89-96.
23. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD, Schlessinger J. 1997. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 16: 978-988.
24. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P, Peles E. 1999. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24: 1037-1047.
25. Poot M, Beyer V, Schwaab I, Damatova N, Van't Slot R, Prothero J, Holder SE, Haaf T. 2010. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11: 81-89. [Epub 2009 Jul 7].
26. Raza MH, Riazuddin S, Drayna D. 2010. Identification of an autosomal recessive stuttering locus on chromosome 3q13.2-3q13.33. Hum Genet. 128: 461-463. [Epub 2010 Aug 13].
27. Riaz N, Steinberg S, Ahmad J, Pluzhnikov A, Riazuddin S, Cox NJ, Drayna D. 2005. Genomewide significant linkage to stuttering on chromosome 12. Am J Hum Genet 76: 647-651.
28. Rossi E, Verri AP, Patricelli MG, Destefani V, Ricca I, Vetro A, Ciccone R, Giorda R, Toniolo D, Maraschio P, Zuffardi O. 2008. A 12-Mb deletion at 7q33-q35 associated with autism spectrum disorders and primary amenorrhea. Eur J Med Genet 51: 631-638.
29. Seeger T, Fedorova I, Zheng F, Miyakawa T, Koustova E, Gomeza J, Basile AS, Alzheimer C, Wess J. 2004. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24: 10117-10127.
30. Shugart YY, Mundorff J, Kilshaw J, Doheny K, Doan B, Wanyee J, Green ED, Drayna D. 2004. Results of a genome-wide linkage scan for stuttering. Am J Med Genet Part A 124A: 133-135.
31. Stromswold K. 2008. The genetics of speech and language impairments. N Engl J Med 359: 2381-2383.
32. Suresh R, Ambrose N, Roe C, Pluzhnikov A, Wittke-Thompson JK, Ng MC, Wu X, Cook EH, Lundstrom C, Garsten M, Ezrati R, Yairi E, Cox NJ. 2006. New complexities in the genetics of stuttering: Significant sex-specific linkage signals. Am J Hum Genet 78: 554-563.
33. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA. 2003. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82: 1-9.
34. Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, Bird LE, Davies KE, Fisher SE. 2006. Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet 15: 3154-3167.
35. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcon M, Oliver PL, Davies KE, Geschwind DH, Monaco AP, Fisher SE. 2008. A functional genetic link between distinct developmental language disorders. N Engl J Med 359: 2337-2345.
36. Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, Kwon JM, Wu W, Dick DM, Rice J, Jones K, Nurnberger JI Jr, Tischfield J, Porjesz B, Edenberg HJ, Hesselbrock V, Crowe R, Schuckit M, Begleiter H, Reich T, Goate AM, Bierut LJ. 2004. Evidence of common and specific genetic effects: Association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13: 1903-1911 .
37. Weksberg R, Hughes S, Moldovan L, Bassett AS, Chow EW, Squire JA. 2005. A method for accurate detection of genomic microdeletions using real-time quantitative PCR. BMC Genomics 6: 180.
38. Wingate ME. 1964. A standard definition of stuttering. J Speech Hear Disord 29: 484-489.
39. Wittke-Thompson JK, Ambrose N, Yairi E, Roe C, Cook EH, Ober C, Cox NJ. 2007. Genetic studies of stuttering in a founder population. J Fluency Disord 32: 33-50.
40. Yairi E, Ambrose NG. 1999. Early childhood stuttering I: Persistency and recovery rates. J Speech Lang Hear Res 42: 1097-1112.